NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Delphi Ventures’

17 April 2014

H.I.G. BioVentures leads $15m VC round for ForSight VISION5

ForSight VISION5 has closed a $15m Series C round led by H.I.G. BioVentures, alongside returning investors Morgenthaler Ventures, Versant Ventures, Technology Partners, and Delphi Ventures.

9 April 2014

Delphi Ventures leads new funding round for Sequent Medical

brain_lrg Delphi Ventures has recommitted to portfolio company Sequent Medical by leading a $20m Series D financing round.

18 November 2013

TriVascular raises $40m Series E from new and existing investors

Medical devices startup TriVascular, which is focused on endovascular aortic repair, has raised a $40m Series E round.

14 November 2013

Insulin pump maker Tandem Diabetes Care surges after IPO

stock brokerage market share listed Venture capital-backed Tandem Diabetes Care surged after its IPO on the Nasdaq exchange, which valued the medical devices company at $15 per share.

29 October 2013

Calithera raises $35m Series D from Adage Capital, existing backers

cancer band pink_sq Venture capital firm Adage Capital Partners has led a $35m Series D round for biotech company Calithera Biosciences, which develops novel cancer therapeutics.

9 October 2013

Venture-backed medical device maker Tandem Diabetes files for $100m IPO

Tandem Diabetes pump Venture capital-backed insulin pump maker Tandem Diabetes has filed to raise $100m through an IPO on the Nasdaq Global Market.

4 February 2013

Ascension Health Ventures joins NEA, Delphi in $27m Ivantis financing

Ascension Health Ventures has led a $27m Series B financing round for eye disease treatment company Ivantis.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014